Benzinga's Top Ratings Upgrades, Downgrades For December 28, 2022

Upgrades

Downgrades

Initiations

Capital One initiated coverage on IDEAYA Biosciences Inc (NASDAQ:IDYA) with an Overweight rating. The price target for IDEAYA Biosciences is set to $29.00. IDEAYA Biosciences earned $0.04 in the third quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.09 and a 52-week-low of $8.14. IDEAYA Biosciences closed at $16.53 at the end of the last trading period.

Janney Montgomery Scott initiated coverage on Generac Holdings Inc (NYSE:GNRC) with a Buy rating. The price target for Generac Hldgs is set to $160.00. For the third quarter, Generac Hldgs had an EPS of $1.75, compared to year-ago quarter EPS of $2.35. At the moment, the stock has a 52-week-high of $357.15 and a 52-week-low of $86.29. Generac Hldgs closed at $91.15 at the end of the last trading period.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Akili Inc (NASDAQ:AKLI). The price target seems to have been set at $2.00 for Akili. The stock has a 52-week-high of $37.58 and a 52-week-low of $0.99. At the end of the last trading period, Akili closed at $1.00.

See all analyst ratings initiations.

GNRCGenerac Holdings Inc

$225.00-0.05%

Overview

IDYAIDEAYA Biosciences Inc

$36.65-%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.